CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- Open-market buys, last 90 days
- $21,250
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$21,250. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-09 | GORDON CARL L Director | Sale | −3,571,428 | $1.59 | $5.7M | 0 |
| 2025-04-09 | ORBIMED ADVISORS LLC Director | Sale | −3,571,428 | $1.59 | $5.7M | 0 |
| 2022-11-25 | Bisker-Leib Vered Chief Operating Officer | Sale | −2 | $4.36 | $9 | 1,060,414 |
| 2022-11-23 | Bisker-Leib Vered Chief Operating Officer | Sale | −9,569 | $4.30 | $41K | 1,060,416 |
| 2022-11-22 | Bisker-Leib Vered Chief Operating Officer | Sale | −14,929 | $4.19 | $63K | 1,069,985 |
| 2022-11-21 | Bisker-Leib Vered Chief Operating Officer | Sale | −16,035 | $4.34 | $70K | 1,084,914 |
| 2022-11-18 | Bisker-Leib Vered Chief Operating Officer | Sale | −6,226 | $4.40 | $27K | 1,107,175 |
Page 1 of 1 · 7 trades